跳至主要内容
临床试验/NCT05065697
NCT05065697Unknown不适用

Brain Lesions After Transcatheter Aortic Valve Replacement

West China Hospital0 个研究点目标入组 150 人开始时间: 2022年1月最近更新:
适应症

试验速览

阶段
不适用
入组人数
150
主要终点
The incidence of new brain embolisms detected on MRI

研究概览

简要总结

The Brain lEsions after TrAnscatheter aorTic ValvE Replacement (BETTER) registry is a prospective, observational, multi-center registry aiming to assess the presence of new brain microbleeds assessed on susceptibility-weighted imaging at 3 enrolling sites, in China (West China Hospital, Sichuan University), UK (St Thomas' Hospital) and Denmark (Rigshospitalet, University of Copenhagen). The main study arm is planned to include 100 patients with symptomatic severe aortic stenosis undergoing transfemoral TAVR of any devices and 50 isolated bioprosthetic SAVR patients treated during the enrollment period as a control arm.

详细描述

"Silent" stroke post-TAVR presents as asymptomatic brain ischemic lesions detected on diffusion-weighted magnetic resonance imaging (DW-MRI), with an incidence ranging from 60% to 100% in different studies. On the contrary, hemorrhagic lesions are not systematically studied given the poor visualization of small hemorrhage (i.e. microbleeds) on traditional T1, T2 or DW-MRI sequences. We have previously identified an incidence of new brain microbleeds early after TAVR of 100% with the routine use of susceptibility-weighted imaging (SWI). We hypothesize that new brain microbleeds are prevalent in patients with aortic stenosis after either TAVR or SAVR. The key objective of this registry is to evaluate the incidence, distribution and clinical impact of new brain microbleeds after transfemoral TAVR in patients with symptomatic severe aortic stenosis, in comparison with SAVR.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
60 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Symptomatic severe aortic stenosis (>60 years old) being scheduled for either transfemoral TAVR or isolated SAVR

排除标准

  • Patients who have been diagnosed with brain cancer, brain haemorrhage, brain abscess, aneurysm, cerebral palsy, encephalitis, nervous system infection, head or neurological injury, or trauma, stroke
  • Contraindications for a magnetic resonance imaging (MRI) scan (i.e. metallic implants, claustrophobia, MR-incompatible pacemakers or prosthetic heart valves)
  • Unremovable dental prostheses that are deemed to affect MRI quality
  • Severe coronary artery disease that is unrevascularized
  • Prior stroke within the last 12 months
  • Expected non-compliance concerning follow-up examinations
  • Have participated in other clinical trials

结局指标

主要结局

The incidence of new brain embolisms detected on MRI

时间窗: Post-procedurally (up to 7 days) and 6 months

Ischemic infarcts (including the number and size) on DW-MRI after TAVR or SAVR during the index hospitalization and their evolution at the follow-up

The incidence of new brain microbleeds detected on MRI

时间窗: Post-procedurally (up to 7 days) and 6 months

Microbleeds (including the number and size) on SWI after TAVR or SAVR during the index hospitalization and their evolution at the follow-up

次要结局

  • Changes in the neurological and cognitive status of the patients (see description for specific assessments)(Post-procedurally (up to 7 days), 6 months and 1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mao Chen

Director of Department of Cardiology

West China Hospital

相似试验

Brain Lesions After Transcatheter Aortic Valve... | 临床试验